MDX health testing for VISN 19 - call order for option year 4
Ended Awarded Last action
- Contract number
- 36C25925N0033
- Awardee
-
Mdxhealth, Inc. UEI LQGYDJJ9K8Q6
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $185,291
Award facts
- Contract value 100% obligated
- $185,290.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$46,463 | |
| Supplemental Agreement for work within scope | -$2,051 | |
| Supplemental Agreement for work within scope | -$2,246 | |
| Supplemental Agreement for work within scope | $12,000 | |
| Original award | $224,051 |
About this award
The Department of Veterans Affairs' Veterans Integrated Service Network 19 (VISN 19) awarded a $185,291 firm fixed-price call order to MDXHealth, Inc. for molecular diagnostic testing services under Option Year 4 of a blanket purchase agreement. The work is scheduled for completion by September 30, 2025, with performance taking place in Aurora, Colorado. This call order represents a continuation of MDXHealth's ongoing provision of specialized cancer diagnostic testing services, including genomic and epigenetic analysis for prostate, lung, and colorectal cancers that support personalized treatment strategies for veterans. The procurement was conducted without a set-aside designation, allowing MDXHealth to compete as a standard commercial vendor under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II).
MDXHealth, Inc., a California-based healthcare company headquartered in Irvine, maintains an active federal contracting presence across multiple VA service networks. The parent blanket purchase agreement from which this call order was issued is valued at $1.424 million with a five-year performance period extending through September 30, 2030. MDXHealth currently holds six active BPAs with the Department of Veterans Affairs across multiple VISNs, with its largest indefinite delivery vehicle—a $4.8 million agreement with VISN 17—supporting Oncotype DX prostate testing services. The company's established infrastructure includes testing facilities in California, Texas, and Colorado, enabling efficient delivery of specialized molecular diagnostic capabilities to support the VA's integrated healthcare system.
Quick answers
Who was awarded contract 36C25925N0033?
36C25925N0033 was awarded to Mdxhealth, Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C25925N0033 worth?
The government has obligated $185,291 on 36C25925N0033.
Is contract 36C25925N0033 an order under another contract?
Yes. 36C25925N0033 is a BPA call under V797D70066-36C25921A0001, a blanket purchase agreement, on Medical Laboratory Testing and Analysis Services (FSS-621-II).
Was contract 36C25925N0033 competed?
The extent of competition for 36C25925N0033 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award